Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

NCT06867562 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Platinum-Resistant Primary Peritoneal Carcinoma
Platinum Resistant High Grade Epithelial Ovarian Cancer
Platinum Resistant High Grade Serous Ovarian Cancer

Interventions

DRUG: Paclitaxel Lipid Suspension
DRUG: Conventional paclitaxel or Taxol

Sponsor

Jina Pharmaceuticals Inc.